Hospital facility prices. What the hospital charges for the
facility side of care — the surgeon’s and anesthesiologist’s
fees are billed separately and are not included.
How we scope prices →
HANK Price Transparency. (n.d.).
PANITUMUMAB 100 MG/5 ML (20 MG/ML) INTRAVENOUS SOLUTION (NDC 55513-954-21) by Hospital.
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved , from http://ppman.hank.ai/transparency/procedure/55513-954-21/by-hospital?code_type=NDC
MLA (9th ed.)
“PANITUMUMAB 100 MG/5 ML (20 MG/ML) INTRAVENOUS SOLUTION (NDC 55513-954-21) by Hospital.” HANK Price Transparency,
http://ppman.hank.ai/transparency/procedure/55513-954-21/by-hospital?code_type=NDC. Accessed
.
Chicago (notes-bibliography)
“PANITUMUMAB 100 MG/5 ML (20 MG/ML) INTRAVENOUS SOLUTION (NDC 55513-954-21) by Hospital,” HANK Price Transparency,
accessed ,
http://ppman.hank.ai/transparency/procedure/55513-954-21/by-hospital?code_type=NDC.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology.
NDC · across hospitals
55513-954-21 — Panitumumab 100 Mg/5 Ml (20 Mg/ml) Intravenous Solution
Hospital-by-hospital median negotiated rates.
Hospitals are ranked by their typical (median) negotiated rate (highest first by default; click a column to re-sort). Outliers are flagged
where a hospital's median is more than 2× or less than 0.5× the
cohort median (red = high, green = low).